Paul Isaac - Arbiter Partners Capital Management 13F Activity & Position Changes (Q3 2024)
According to the SEC 13F filed on Nov 13, 2024, the Arbiter Partners Capital Management portfolio showed several notable changes in holdings as of quarter-end Sep 30, 2024. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.
During Q3 2024, the filing reported:
New Buys - Inhibrx Biosciences, Inc.
Increases - GRAIL, Inc., Stereotaxis, Inc.
These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.
Showing 10 of 10 transactions.
| Date | Symbol | Type | Change Qty |
|---|---|---|---|
|
Q3 2024
|
GEG
Great Elm Group, Inc.
|
Sell - Position Exit |
-255,728
|
|
Q3 2024
|
GRAL
GRAIL, Inc.
|
Buy |
+129,108
|
|
Q3 2024
|
INBX
Inhibrx Biosciences, Inc.
|
Buy - Position Entry |
+28,095
|
|
Q3 2024
|
LEN-B
Lennar Corporation
|
Sell |
-798
|
|
Q3 2024
|
LH
Labcorp Holdings Inc.
|
Sell - Position Exit |
-8,100
|
|
Q3 2024
|
LILAK
Liberty Latin America Ltd
|
Sell |
-10,000
|
|
Q3 2024
|
LNC
Lincoln National Corporation
|
Sell - Position Exit |
-11,000
|
|
Q3 2024
|
LRFC
Logan Ridge Finance Corporation
|
Sell |
-842
|
|
Q3 2024
|
SNDA
Sonida Senior Living, Inc.
|
Sell |
-42,646
|
|
Q3 2024
|
STXS
Stereotaxis, Inc.
|
Buy |
+9,349
|